(MedPage Today) -- The FDA has once again denied approval of long-acting testosterone undecanoate injection (Aveed) for men with hypogonadism, drugmaker Endo Pharmaceuticals has announced. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment